Cargando…

Author Correction: LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer

Detalles Bibliográficos
Autores principales:	Li, Qiuhui, Liu, Bigang, Chao, Hsueh-Ping, Ji, Yibing, Lu, Yue, Mehmood, Rashid, Jeter, Collene, Chen, Taiping, Moore, John R., Li, Wenqian, Liu, Can, Rycaj, Kiera, Tracz, Amanda, Kirk, Jason, Calhoun-Davis, Tammy, Xiong, Jie, Deng, Qu, Huang, Jiaoti, Foster, Barbara A., Gokhale, Abhiram, Chen, Xin, Tang, Dean G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272421/ https://www.ncbi.nlm.nih.gov/pubmed/32499578 http://dx.doi.org/10.1038/s41467-020-16615-9

Ejemplares similares

LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer
por: Li, Qiuhui, et al.
Publicado: (2019)

LRIG1, a regulator of stem cell quiescence and a pleiotropic feedback tumor suppressor
por: Ji, Yibing, et al.
Publicado: (2022)

NANOG reprograms prostate cancer cells to castration resistance via dynamically repressing and engaging the AR/FOXA1 signaling axis
por: Jeter, Collene R, et al.
Publicado: (2016)

miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cells
por: Liu, Ruifang, et al.
Publicado: (2016)

Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses
por: Li, Qiuhui, et al.
Publicado: (2018)

NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation
por: Jeter, Collene R., et al.
Publicado: (2011)

Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells
por: Liu, Xin, et al.
Publicado: (2015)

Transgenic overexpression of NanogP8 in the mouse prostate is insufficient to initiate tumorigenesis but weakly promotes tumor development in the Hi-Myc mouse model
por: Liu, Bigang, et al.
Publicado: (2017)

Nanog1 in NTERA-2 and Recombinant NanogP8 from Somatic Cancer Cells Adopt Multiple Protein Conformations and Migrate at Multiple M.W Species
por: Liu, Bigang, et al.
Publicado: (2014)

Longitudinal tracking of subpopulation dynamics and molecular changes during LNCaP cell castration and identification of inhibitors that could target the PSA−/lo castration-resistant cells
por: Rycaj, Kiera, et al.
Publicado: (2016)

Lrig1 is a haploinsufficient tumor suppressor gene in malignant glioma
por: Mao, Feng, et al.
Publicado: (2018)

Evidence for context-dependent functions of KDM5B in prostate development and prostate cancer
por: Liu, Bigang, et al.
Publicado: (2020)

Developing a Novel Two‐Dimensional Culture System to Enrich Human Prostate Luminal Progenitors that Can Function as a Cell of Origin for Prostate Cancer
por: Zhang, Dingxiao, et al.
Publicado: (2016)

The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma
por: Cheng, Fangling, et al.
Publicado: (2019)

Histone 2B-GFP Label-Retaining Prostate Luminal Cells Possess Progenitor Cell Properties and Are Intrinsically Resistant to Castration
por: Zhang, Dingxiao, et al.
Publicado: (2017)

LRIG and cancer prognosis
por: Lindquist, David, et al.
Publicado: (2014)

Corrigendum: The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma
por: Cheng, Fangling, et al.
Publicado: (2020)

Identification of miR-34a as a potent inhibitor of prostate cancer progenitor cells and metastasis by directly repressing CD44
por: Liu, Can, et al.
Publicado: (2011)

Dissociated Primary Human Prostate Cancer Cells Coinjected with the Immortalized Hs5 Bone Marrow Stromal Cells Generate Undifferentiated Tumors in NOD/SCID-γ Mice
por: Chen, Xin, et al.
Publicado: (2013)

LRIG1 is a triple threat: ERBB negative regulator, intestinal stem cell marker and tumour suppressor
por: Wang, Y, et al.
Publicado: (2013)

Plant responses to extracellular nucleotides: Cellular processes and biological effects
por: Jeter, Collene R., et al.
Publicado: (2006)

Molecular determinants of prostate cancer metastasis
por: Rycaj, Kiera, et al.
Publicado: (2017)

Pleiotropic tumor suppressor functions of WWOX antagonize metastasis
por: Khawaled, Saleh, et al.
Publicado: (2020)

The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status
por: Johansson, Mikael, et al.
Publicado: (2013)

MicroRNA-141 suppresses prostate cancer stem cells and metastasis by targeting a cohort of pro-metastasis genes
por: Liu, Can, et al.
Publicado: (2017)

LRIG1 expression and colorectal cancer prognosis
por: Bakherad, Maryam, et al.
Publicado: (2021)

The Prognostic Role of LRIG Proteins in Endometrial Cancer
por: Razumova, Zoia, et al.
Publicado: (2021)

In vivo functional studies of tumor-specific retrogene NanogP8 in transgenic animals
por: Badeaux, Mark A, et al.
Publicado: (2013)

Lrig1 Expression in Human Sebaceous Gland Tumors
por: Pünchera, Jöri, et al.
Publicado: (2016)

Vertebrate Lrig3-ErbB Interactions Occur In Vitro but Are Unlikely to Play a Role in Lrig3-Dependent Inner Ear Morphogenesis
por: Abraira, Victoria E., et al.
Publicado: (2010)

Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer
por: Zhang, Dingxiao, et al.
Publicado: (2016)

The soluble form of pan-RTK inhibitor and tumor suppressor LRIG1 mediates downregulation of AXL through direct protein–protein interaction in glioblastoma
por: Neirinckx, Virginie, et al.
Publicado: (2019)

USP8 modulates ubiquitination of LRIG1 for Met degradation
por: Oh, Young Mi, et al.
Publicado: (2014)

Lrig1 is a positive prognostic marker in hepatocellular carcinoma
por: Yang, Bo, et al.
Publicado: (2016)

LRIG2 regulates cell proliferation, migration and apoptosis of osteosarcoma
por: Li, Zhi-Qiang, et al.
Publicado: (2022)

LRIG2 expression and prognosis in non-small cell lung cancer
por: WANG, GUANGCHUAN, et al.
Publicado: (2014)

Lrig2-Deficient Mice Are Protected against PDGFB-Induced Glioma
por: Rondahl, Veronica, et al.
Publicado: (2013)

LRIG1 negatively regulates RET mutants and is downregulated in thyroid cancer
por: Lindquist, David, et al.
Publicado: (2018)

Expression of LRIG proteins as possible prognostic factors in primary vaginal carcinoma
por: Ranhem, Cecilia, et al.
Publicado: (2017)

The transmembrane protein LRIG2 increases tumor progression in skin carcinogenesis
por: Hoesl, Christine, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ulh5gtekmcj0ookcmmlmsvhsa0